• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

NOVAVAX, INC.

Notes

No. Proposition For Against Abstain
1

Election of Class III Director to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders: Rachel K. King

2

Election of Class III Director to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders: John W. Shiver, Ph.D.

3

Election of Class III Director to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders: Charles W. Newton

4

The approval, on an advisory basis, of the compensation of our Named Executive Officers.

5

Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.